XML 24 R11.htm IDEA: XBRL DOCUMENT
v3.22.1

REVENUES | 3 Months Ended
--- | ---
Mar. 31, 2022
REVENUES |
REVENUES | NOTE 4 – REVENUES The following table summarizes the Company’s disaggregation of revenues: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months Ended March 31,
(U.S. dollars in thousands) |  | 2022 |  | 2021
Pfizer | ​ | $ | 3,356 | ​ | $ | 4,511
Brazil | ​ | $ | 5,454 | ​ | $ | —
Chiesi | ​ | $ | 218 | ​ | $ | —
Total revenues from selling goods | ​ | $ | 9,028 | ​ | $ | 4,511
Revenues from license and R&D services | ​ | $ | 7,057 | ​ | $ | 6,809
​

X
- Definition The entire disclosure pertaining to revenue. + References No definition available. + Details
Name: | plx_RevenueDisclosureTextBlock
Namespace Prefix: | plx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAndDeferredRevenueAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration